Venus Remedies Ltd.
| BSE: 526953 | Sector: Health care |
| NSE: VENUSREM | ISIN Code: INE411B01019 |
| BSE 00:00 | 15 Jan | 170.40 |
8.10 (4.99%) |
OPEN
167.90 |
HIGH
170.40 |
LOW
162.05 |
| NSE 00:00 | 15 Jan | 172.05 |
8.10 (4.94%) |
OPEN
163.95 |
HIGH
172.10 |
LOW
162.15 |
| OPEN | 167.90 |
| PREVIOUS CLOSE | 162.30 |
| VOLUME | 5120 |
| 52-Week high | 191.50 |
| 52-Week low | 21.20 |
| P/E | 7.59 |
| Mkt Cap.(Rs cr) | 210 |
| Buy Price | 170.40 |
| Buy Qty | 503.00 |
| Sell Price | 169.25 |
| Sell Qty | 12.00 |
Venus Remedies Ltd. (VENUSREM) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Biocon | 456.75 | -10.00 | -2.14 | 440.90 |
| Sanofi India | 8336.25 | -72.55 | -0.86 | 414.20 |
| Syngene Intl. | 603.25 | -11.20 | -1.82 | 411.50 |
| IOL Chemicals | 717.35 | -18.35 | -2.49 | 361.29 |
| Jubilant Life | 975.65 | -29.20 | -2.91 | 321.14 |
| ERIS Lifescience | 624.50 | 8.95 | 1.45 | 291.27 |
| Suven Pharma | 502.55 | -0.10 | -0.02 | 270.08 |
| J B Chem & Pharm | 1041.90 | 8.00 | 0.77 | 268.14 |
| Laurus Labs | 369.75 | 2.70 | 0.74 | 267.05 |
| P & G Health Ltd | 6801.65 | 15.55 | 0.23 | 254.08 |
| FDC | 325.10 | -3.90 | -1.19 | 246.78 |
| Dr Lal Pathlabs | 2293.75 | -40.35 | -1.73 | 223.18 |
| Caplin Point Lab | 487.00 | -4.65 | -0.95 | 197.64 |
| Shilpa Medicare | 438.05 | 1.25 | 0.29 | 193.72 |
| Piramal Enterp. | 1624.45 | 27.75 | 1.74 | 144.85 |
| Aarti Drugs | 707.50 | -8.60 | -1.20 | 135.67 |
| Metropolis Healt | 2164.00 | -11.40 | -0.52 | 112.05 |
| Solara Active | 1220.90 | -21.90 | -1.76 | 112.49 |
| Strides Pharma | 908.45 | -12.90 | -1.40 | 111.70 |
| Glaxosmi. Pharma | 1515.90 | -1.40 | -0.09 | 110.05 |
Quick Links for Venus Remedies:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
